Correlation Between Crinetics Pharmaceuticals and Sanofi ADR

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Sanofi ADR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Sanofi ADR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Sanofi ADR, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Sanofi ADR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Sanofi ADR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Sanofi ADR.

Diversification Opportunities for Crinetics Pharmaceuticals and Sanofi ADR

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Crinetics and Sanofi is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Sanofi ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sanofi ADR and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Sanofi ADR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sanofi ADR has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Sanofi ADR go up and down completely randomly.

Pair Corralation between Crinetics Pharmaceuticals and Sanofi ADR

Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 2.12 times more return on investment than Sanofi ADR. However, Crinetics Pharmaceuticals is 2.12 times more volatile than Sanofi ADR. It trades about 0.12 of its potential returns per unit of risk. Sanofi ADR is currently generating about -0.23 per unit of risk. If you would invest  5,123  in Crinetics Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of  892.00  from holding Crinetics Pharmaceuticals or generate 17.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Crinetics Pharmaceuticals  vs.  Sanofi ADR

 Performance 
       Timeline  
Crinetics Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Crinetics Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Crinetics Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Sanofi ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sanofi ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Crinetics Pharmaceuticals and Sanofi ADR Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Crinetics Pharmaceuticals and Sanofi ADR

The main advantage of trading using opposite Crinetics Pharmaceuticals and Sanofi ADR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Sanofi ADR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sanofi ADR will offset losses from the drop in Sanofi ADR's long position.
The idea behind Crinetics Pharmaceuticals and Sanofi ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets